RTI Surgical Celebrates First Human Implantation of map3™ Cellular Allogeneic Bone Graft

Published: Aug 12, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is pleased to announce that the first human implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant was completed last week.

Help employers find you! Check out all the jobs and post your resume.

Back to news